Related Experiment Video
Updated: May 17, 2026

High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
Trans-acting antigenomic HDV ribozyme for production of in vitro transcripts with homogenous 3' ends
Milena Szafraniec1, Leszek Blaszczyk, Jan Wrzesinski
1Institute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Abstract:
During in vitro run-off transcription with T7 RNA polymerase, transcripts with heterogenous 3' ends are commonly synthesized. Here, we describe an efficient procedure for correct processing of transcript 3' ends with the use of antigenomic HDV ribozyme. The procedure involves the extension of nascent transcripts with seven nucleotides complementary to the ribozyme's recognition site and, subsequently, the removal of those nucleotides with the HDV ribozyme acting in trans. Sufficient reaction rates and final cleavage extents of approx. 90% can be obtained with just twofold excess of the ribozyme. The highest concentration of RNA substrate suggested for practical applications turns out to be 3 μM. The procedure is an alternative to the use of ribozymes as cis-cleaving autocatalytic cassettes attached to transcript 3' ends.
Related Concept Videos
Viruses with RNA Genomes
Leaky Scanning

